India has long been known as the "pharmacy of the world" because it produces affordable medicines and vaccines. However, when it comes to developing new drugs, especially antibiotics, the country has been largely absent from the spotlight. But that is about to change with Nafithromycin, a breakthrough drug that could transform global healthcare. Expected to be available by 2025 under the brand name Miqnaf, Nafithromycin is India's first ever indigenously developed antibiotic to fight resistant ...